Medi-Caps Q3FY26 Results: Mixed Performance Across Segments

Medi-Caps Limited reported Q3FY26 results with standalone profit of ₹28.50 lacs but consolidated loss of ₹76.58 lacs. Real estate division showed improvement while pharma segment faced challenges.

Medi-Caps Limited Reports Financial Results for Quarter and Half-Year Ended September 30, 2025

Medi-Caps Limited's Board of Directors approved unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2025. The company generated revenue of Rs. 99.78 lakhs from sale of shops at Medi-caps Business Park during the quarter. The consolidated results include subsidiary Medgel Private Limited, which reported total assets of Rs. 2,566.22 lakhs, total income of Rs. 101.25 lakhs, and net loss after tax of Rs. 210.80 lakhs for the quarter. The company operates two reportable segments - Pharma division and Real Estate division. The financial results were reviewed by statutory auditors and will be published in newspapers and uploaded on company and stock exchange websites.

Medi-Caps Limited Reports Q1 FY2026 Results, Schedules 42nd AGM for September 2025

Medi-Caps Limited approved unaudited standalone and consolidated financial results for the quarter ended June 30, 2025. On standalone basis, the company reported a net loss of Rs 39.75 lakhs compared to a profit of Rs 33.17 lakhs in the same quarter last year, with no revenue from operations during the quarter. On consolidated basis, revenue from operations was Rs 268.76 lakhs versus Rs 619.44 lakhs in the previous year quarter, while net loss widened to Rs 349.19 lakhs from Rs 57.10 lakhs. The board scheduled the 42nd Annual General Meeting for September 18, 2025, and approved the appointment of Joshi Sahay and Company as Secretarial Auditor for five years from FY 2025-2026 to FY 2029-2030. The board also approved the re-appointment of Mr. Dharmendra Solanki as Non Executive Independent Director for a second five-year term from February 5, 2026 to February 4, 2031, subject to shareholder approval.

Medi-Caps Limited Re-appoints Dharmendra Solanki as Independent Director for Second Five-Year Term

Medi-Caps Limited's Board of Directors approved the re-appointment of Mr. Dharmendra Solanki as Non-Executive Independent Director for a second term of five years, from February 5, 2026, to February 4, 2031. The re-appointment is subject to shareholder approval at the company's 42nd Annual General Meeting. Solanki holds a Bachelor's and Master's degree in commerce from Vikram University, Ujjain, and has 27 years of post-qualification experience in accounts, finance, and taxation. The company confirmed that Solanki is not related to any other directors and is not debarred from accessing capital markets by SEBI or any other authority.